Ype Elgersma

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications

Phosphoproteomic Analysis of Cortical Tissue from Mice Lacking Both CaMKIIα and CaMKIIβ Identifies Novel In Vivo Substrates.

Phosphoproteomic Analysis of Cortical Tissue from Mice Lacking Both CaMKIIα and CaMKIIβ Identifies Novel In Vivo Substrates.

Journal: ACS chemical neuroscience
Published: February 25, 2026

A xenotransplantation model for reactivation of paternal UBE3A using human-specific antisense oligonucleotides.

A xenotransplantation model for reactivation of paternal UBE3A using human-specific antisense oligonucleotides.

Journal: Scientific reports
Published: November 25, 2025

Navigating Human Astrocyte Differentiation: Direct and Rapid One-Step Differentiation of Induced Pluripotent Stem Cells to Functional Astrocytes Supporting Neuronal Network Development.

Navigating Human Astrocyte Differentiation: Direct and Rapid One-Step Differentiation of Induced Pluripotent Stem Cells to Functional Astrocytes Supporting Neuronal Network Development.

Journal: Glia
Published: October 31, 2025

UBE3A isoform-selective and non-selective contributions to Angelman syndrome phenotypes.

UBE3A isoform-selective and non-selective contributions to Angelman syndrome phenotypes.

Journal: Molecular psychiatry
Published: October 17, 2025

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome.

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome.

Journal: Journal of neurodevelopmental disorders
Published: September 16, 2025

UBE3A reinstatement restores behaviorand proteome in an Angelman syndrome mouse model of imprinting defects.

UBE3A reinstatement restores behaviorand proteome in an Angelman syndrome mouse model of imprinting defects.

Journal: Molecular autism
Published: December 19, 2024

CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice.

CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice.

Journal: Basic & clinical pharmacology & toxicology
Published: September 05, 2024

Model matchmaking via the Solve-RD Rare Disease Models & Mechanisms Network (RDMM-Europe).

Model matchmaking via the Solve-RD Rare Disease Models & Mechanisms Network (RDMM-Europe).

Journal: Lab animal
Published: June 24, 2024

The effect of lamotrigine on cortical inhibition and plasticity in Neurofibromatosis type 1: Exploratory analysis of a randomized controlled trial (NF1-EXCEL).

The effect of lamotrigine on cortical inhibition and plasticity in Neurofibromatosis type 1: Exploratory analysis of a randomized controlled trial (NF1-EXCEL).

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: June 03, 2024

Modeling mTORopathy-related epilepsy in cultured murine hippocampal neurons using the multi-electrode array.

Modeling mTORopathy-related epilepsy in cultured murine hippocampal neurons using the multi-electrode array.

Journal: Experimental neurology
Published: April 24, 2024

Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics.

Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics.

Journal: Therapeutic advances in rare disease
Published: March 11, 2024

Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies.

Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies.

Journal: Nature communications
Published: February 06, 2024
Showing 1-12 of 117

Last Updated: 09/26/2026